CD8A and neoplasm: Among all components of the TME, the prior recruitment of tumor-infiltrating lymphocytes (TILs), particularly CD8+ cytotoxic T-lymphocytes, placed intratumorally and along tumor margins can impact the outcome of checkpoint blockades [41].